ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZYME ZYMEWORKS INC (US)

Market Closed 09-11 16:00:00 EDT

26.24

-0.19

-0.74%

盘后26.07

-0.17-0.65%

19:30 EDT

High26.99	Low26.03	Vol1.03M
Open26.62	D1 Closing26.44	Amplitude3.63%
Mkt Cap1.86B	Tradable Cap1.73B	Total Shares70.96M
T/O27.15M	T/O Rate1.56%	Tradable Shares66.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZYME","market":"US","secType":"STK","nameCN":"ZYMEWORKS INC (US)","latestPrice":26.24,"timestamp":1789156800000,"preClose":26.435,"halted":0,"volume":1030812,"hourTrading":{"tag":"盘后","latestPrice":26.07,"preClose":26.24,"latestTime":"19:30 EDT","volume":837785,"amount":21983538.4985,"timestamp":1789169408182,"change":-0.17,"changeRate":-0.006479,"amplitude":0.006479},"delay":0,"changeRate":-0.007376584074144138,"floatShares":66047299,"shares":70959241,"eps":-2.02,"marketStatus":"Market Closed","change":-0.195,"latestTime":"09-11 16:00:00 EDT","open":26.62,"high":26.99,"low":26.03,"amount":27152937.412908,"amplitude":0.036315,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.02,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1493352000000,"exchange":"NASDAQ","adjPreClose":26.435,"preHourTrading":{"tag":"盘前","latestPrice":26.87,"preClose":26.435,"latestTime":"09:29 EDT","volume":458,"amount":12227.343248,"timestamp":1789133399999,"change":0.435,"changeRate":0.016455,"amplitude":0.076648},"postHourTrading":{"tag":"盘后","latestPrice":26.07,"preClose":26.24,"latestTime":"19:30 EDT","volume":837785,"amount":21983538.4985,"timestamp":1789169408182,"change":-0.17,"changeRate":-0.006479,"amplitude":0.006479},"volumeRatio":1.9144922109379396,"impliedVol":0.746,"impliedVolPercentile":0.7371},"requestUrl":"/m/hq/s/ZYME/wiki","defaultTab":"wiki","newsList":[{"id":"2666996625","title":"Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666996625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666996625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047034,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zymeworks-zyme-axsome-therapeutics-axsm-and-ocugen-ocgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4137","LU2324357040.USD","BK4581","BK4568","BK4588","LABU","LU0029874061.USD","BK4585","AXSM","BK4563","XBI","BK4505","OCGN","PTH","XLV","LU0128526141.USD","ZYME","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596964","title":"Theravance Biopharma Announces Shareholder Meeting on Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596964","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596964?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:11","pubTimestamp":1789045912,"startTime":"0","endTime":"0","summary":"Theravance Biopharma announces shareholder meeting on merger dealTheravance Biopharma shareholders will meet on Sept. 18, 2026 in South San Francisco, California.Vote scheduled on the proposed merger ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8Lq0hz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ZYME","TBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745771","title":"Zymeworks (ZYME) Secures FDA Approval And $250 Million Milestone, Is The Stock Still Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745771","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:18","pubTimestamp":1787807892,"startTime":"0","endTime":"0","summary":"The latest move in Zymeworks (ZYME) stock comes after the U.S. FDA approved Ziihera, or zanidatamab hrii, for first line treatment of certain HER2 positive gastroesophageal cancers, triggering a US$250 million milestone from partner Jazz Pharmaceuticals.\nThe FDA decision appears to have reinforced investor confidence in Zymeworks, with the stock posting a 27.41% 1 month share price return and a 96.28% 1 year total shareholder return, while the 298.71% 3 year total shareholder return points to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-zyme/zymeworks/news/zymeworks-zyme-secures-fda-approval-and-250-million-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LABU","BK4139","BK4585","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662179044","title":"Zymeworks price target raised to $38 from $37 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2662179044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662179044?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:35","pubTimestamp":1787740535,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Zymeworks (ZYME) to $38 from $37 and keeps a Buy rating on the shares after the company and its partners rec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-38-from-37-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-38-from-37-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797043","title":"Zymeworks Price Target Raised to $55.00/Share from $51.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797043","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797043?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:22","pubTimestamp":1787739720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662972107","title":"Zymeworks price target raised to $55 from $51 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2662972107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662972107?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739011,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Zymeworks (ZYME) to $55 from $51 and keeps a Buy rating on the shares after the company’s partner...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-55-from-51-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-55-from-51-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662791996","title":"Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662791996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662791996?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:10","pubTimestamp":1787735414,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zymeworks (ZYME) and Johnson & Johnson (JNJ) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-zymeworks-zyme-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-zymeworks-zyme-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","LU1674673428.USD","IE00B1BXHZ80.USD","IYH","LU1430594728.SGD","IE00B7SZLL34.SGD","BMED","LU0320765646.SGD","LU1267930813.SGD","LU0203345920.USD","LU1032955483.USD","BK4559","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0943347566.SGD","IE00BKVL7J92.USD","LU1066051811.HKD","LU1244550577.SGD","LU1551013342.USD","MEDX","SG9999013999.USD","LU1732799900.SGD","LU0345769128.USD","LU1061106388.HKD","LU1023059063.AUD","LU2430703251.USD","LU1280957306.USD","LU2602419157.SGD","LU1983299246.USD","IE00BN8TJ469.HKD","LU0234570918.USD","LU0345770308.USD","TRUH","LU1718418525.SGD","LU1066051498.USD","LU2129689514.USD","LU0234572021.USD","BK4007","LU2756315318.SGD","SG9999001440.SGD","BK4532","LU0072461881.USD","LU0882574055.USD","SGXZ57979304.SGD","LU2129689431.USD","LU1894683348.USD","IE0001KFT4U8.USD","IE00B19Z3581.USD","IE0009355771.USD","LU0345770993.USD","LU2468319806.SGD","LU1043141123.HKD","LU1261432733.SGD","IE00BLSP4239.USD","LU0210528500.USD","LU1914381329.SGD","LU2750360997.AUD","LU0689626769.HKD","LU0689472784.USD","LU1629891620.HKD","LU0912757837.SGD","LU2430703095.HKD","LU0124676726.USD","BK4592","IE00BBT3K403.USD","LU0053666078.USD","LU2089984988.USD","LU1674673691.USD","LU2471134523.USD","IE00B3PB1722.GBP","LU2430703178.SGD","LU2456880835.USD","SG9999001176.USD","LU1066053197.SGD","BK4550","LU0889566641.SGD","LU1228905037.USD","RXL","LU2112291526.USD","GDOC","LU1145028129.USD","JNJ","IE0034235303.USD","BK4581","IE00B3T34201.USD","BK4585","LU1221951046.USD","LU0426412945.USD","IE0002270589.USD","IE00B2B36J28.USD","ZYME","LU0098860793.USD","LU0432979614.USD","LU0640476718.USD","LU1032466523.USD","LU2487616109.SGD","LU0070217475.USD","LU0795875086.SGD","LU2471134796.USD","SG9999002232.USD","LU1585245621.USD","LU0795875169.SGD","LU2505996681.GBP","IE00BFXG1179.USD","LU0820561909.HKD","LU1244550494.USD","LU2505996509.AUD","BK4533","LU1221951129.SGD","LU2236285917.USD","LU2417539215.USD","LU2896262040.SGD","LU0985320562.USD","LU2403377893.USD","LU1894683264.USD","IE00BJJMRZ35.SGD","IE000WAW04H5.SGD","LU1066051225.USD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1732800096.USD","FHLC","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0210536198.USD","BK4588","FTXH","IE000M9KFDE8.USD","LU1989771016.USD","LU1196500208.SGD","IE000SO60NU8.SGD","IE00BSNM7G36.USD","LU2129689605.HKD","LU2592432038.USD","IE00BJT1NW94.SGD","LU1496350502.SGD","SG9999002224.SGD","LU0683600562.USD","VHT","LU0820561818.USD","LU2023250330.USD","IE0000B7K699.USD","LU0792757196.USD","BK4534","LU0203347892.USD","LU0426417589.USD","LU1074936037.SGD","LU0964807845.USD","IHE","LU1043141396.HKD","LU1506573853.SGD","LU0058720904.USD","LU2471134952.CNY","IE00BZ1G4Q59.USD","LU2750360641.GBP","LU1929549753.HKD","LU1162221912.USD","LU0994945656.USD","PJP","LU1059921491.USD","SGXZ80539844.SGD","LU2213496289.HKD","IE00BFTCPJ56.SGD","LU0545562505.USD","LU1244550221.USD","IE00BVYPNW00.USD","IE00BGHQF631.EUR","IE00BDGV0183.EUR","LU1551013425.SGD","LU0162691827.USD","JDOC","BK4568","LU2347655156.SGD","LU0122379950.USD","LU1121112475.USD","BK4504","IE00B42XCP33.USD","LU0114720955.EUR","IE000MB6IJN5.SGD","BK4139","LU0289739699.SGD","IE000F7OJYX1.SGD","LU1778281490.HKD","LU2133065610.SGD","LU0466842654.USD","IE000BZT7R73.USD","LU1057294990.SGD","LU0787776722.HKD","SG9999001176.SGD","IE0002141913.USD","LU2756315664.SGD","LU1935042991.SGD","LU0345769631.USD","LU1228905540.USD","LU0820562030.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662975844","title":"Jazz Wins FDA Approval for Ziihera Regimens in First-Line HER2+ Gastroesophageal Cancer, Triggering USD 250 Million Zymeworks Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2662975844","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662975844?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:23","pubTimestamp":1787667814,"startTime":"0","endTime":"0","summary":"Jazz wins FDA approval for Ziihera regimens in first-line HER2+ gastroesophageal cancer, triggering USD 250 million Zymeworks milestoneFDA cleared two first-line Ziihera (zanidatamab-hrii) regimens fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL1lvDZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014039.USD","ZYME","IE00BKPKM429.USD","IE00BN0W2T93.GBP","BK4139","SG9999014021.USD","IE00BQXX3F31.USD","BK4585","BCDF","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","IE00BN0W2V16.EUR","BK4588","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662584907","title":"U.S. FDA Approves Ziihera® (Zanidatamab-Hrii) with and Without Tislelizumab Plus Chemotherapy in First-Line Her2+ Advanced Gastroesophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662584907","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662584907?lang=en_us&edition=fundamental","pubTime":"2026-08-25 22:23","pubTimestamp":1787667793,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUAC8R4G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659718781","title":"Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659718781","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659718781?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:25","pubTimestamp":1786587936,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Gregory Renza maintained a Buy rating on Zymeworks on August 11 and set a price target of $32.00. The company’s shares clo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-zymeworks-zyme-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-zymeworks-zyme-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658161999","title":"Zymeworks Management Attends Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2658161999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658161999?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:00","pubTimestamp":1786442412,"startTime":"0","endTime":"0","summary":"Zymeworks management attends Wells Fargo Healthcare Conference fireside chatZymeworks will attend investor conferences in early to mid-September, including Wells Fargo on Sept. 8 in Boston.Management ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL24m5rQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","IE00BKVL7J92.USD","KBWB","LU1548497426.USD","BK4585","LU0128525689.USD","LU2111349929.HKD","LU2462157665.USD","LU0006306889.USD","LU2487616109.SGD","LU1363072403.SGD","BCDF","LU0882574139.USD","LU1791710582.SGD","LU1988902786.USD","NDAQ","TFNS","LU0528227936.USD","IE00BN0W2T93.GBP","FTXO","BK4207","LU0314106906.USD","LU1732800096.USD","IAI","BK4566","LU2264538146.SGD","BK4581","IE00B775SV38.USD","SG9999014013.SGD","LU1989772923.USD","IE00BN0W2W23.USD","LU2095319765.USD","LU0170899867.USD","LU0162691827.USD","LU0052756011.USD","BK4504","BK4112","IYF","LU0106261372.USD","LU0971096721.USD","LU1064131342.USD","BK4516","LU1989772840.SGD","LU2125154935.USD","LU0130102774.USD","LU0234570918.USD","BK4127","LU0314104364.USD","ZYME","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658535479","title":"Zymeworks Price Target Raised to $44.00/Share from $40.00 by B. Riley Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535479","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535479?lang=en_us&edition=fundamental","pubTime":"2026-08-11 01:30","pubTimestamp":1786383000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZYME/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658532939","title":"Ireland's Theravance Biopharma Q2 Revenue Rises 11% but Misses Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658532939","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658532939?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:42","pubTimestamp":1786365751,"startTime":"0","endTime":"0","summary":"Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimatesOverviewIreland-based specialty pharma's Q2 revenue rose 11% yr/yr but missed analyst expectationsAdjusted net income for Q2 bea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0289739343.SGD","LU2463526074.USD","LU0154245673.USD","LU0154245756.USD","TBPH","LU0203347892.USD","BK4588","LU0124676726.USD","CMI","BK4567","IE000M9KFDE8.USD","LU0203345920.USD","LU0689626769.HKD","BK4585","BK4149","LU0511384066.AUD","BK4533","MADE","LU0057025933.USD","HRTX","LU0472753341.HKD","ZYME","LU0069063385.USD","BK4139","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936030","title":"B. Riley Adjusts Zymeworks Price Target to $44 From $40, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936030","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936030?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:29","pubTimestamp":1786364965,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Zymeworks Price Target to $44 From $40, Maintains Buy Rating","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644089","title":"Zymeworks price target raised to $32 from $31 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644089?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:25","pubTimestamp":1786112733,"startTime":"0","endTime":"0","summary":"Truist analyst Gregory Renza raised the firm’s price target on Zymeworks (ZYME) to $32 from $31 and keeps a Buy rating on the shares. Zymeworks ent...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-32-from-31-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-price-target-raised-to-32-from-31-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369339","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369339?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:00","pubTimestamp":1786071647,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zymeworks (ZYME), Surrozen (SRZN) and Health Catalys...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-285?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-285?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRZN","BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657566646","title":"Zymeworks Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657566646","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657566646?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:50","pubTimestamp":1786053044,"startTime":"0","endTime":"0","summary":"Zymeworks Inc. reports results for the quarter ended June 30 - Earnings SummaryZymeworks Inc.ZYME.OQreported a quarterly adjusted loss of 62 cents per share for the quarter ended June 30, lower than t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650227","title":"Zymeworks Revenue Drops 90.57% to $4.6 Million in FY26 Q2; Net Loss Widens to $45 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650227","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650227?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:22","pubTimestamp":1786047720,"startTime":"0","endTime":"0","summary":"Zymeworks revenue drops 90.57% to $4.6 million in FY26 Q2; net loss widens to $45 millionZymeworks posted a GAAP net loss of $45.02 million in Q2 2026, swinging from net income of $2.32 million a year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8BXf4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU2095319765.USD","BK4588","SG9999014039.USD","LU2210150020.SGD","NDAQ","ZYME","LU2210149790.SGD","BK4112","BCDF","SG9999014005.SGD","BK4585","IE00BKPKM429.USD","LU0314104364.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","BK4007","IE00BGHQF748.EUR","TBPH","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657930","title":"Zymeworks Q2 EPS $(0.62) Misses $(0.41) Estimate, Sales $4.590M Miss $18.011M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657930","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657930?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:07","pubTimestamp":1786046852,"startTime":"0","endTime":"0","summary":"Zymeworks Q2 EPS $(0.62) Misses $(0.41) Estimate, Sales $4.590M Miss $18.011M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ZYME","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Zymeworks Q2 EPS $(0.62) Misses $(0.41) Estimate, Sales $4.590M Miss $18.011M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZYME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650101","title":"Zymeworks Q2 EPS USD -0.62 VS. Ibes Estimate USD -0.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650101?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046713,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXWX9S2W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zymeworks.com","stockEarnings":[{"period":"1week","weight":-0.1011},{"period":"1month","weight":0.0525},{"period":"3month","weight":0.1469},{"period":"6month","weight":0.1469},{"period":"1year","weight":0.6078},{"period":"ytd","weight":-0.0034}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015488},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.056871},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.020874},{"month":4,"riseRate":0.666667,"avgChangeRate":0.045958},{"month":5,"riseRate":0.3,"avgChangeRate":0.007371},{"month":6,"riseRate":0.6,"avgChangeRate":-0.037508},{"month":7,"riseRate":0.4,"avgChangeRate":-0.043919},{"month":8,"riseRate":0.9,"avgChangeRate":0.127765},{"month":9,"riseRate":0.4,"avgChangeRate":0.023954},{"month":10,"riseRate":0.666667,"avgChangeRate":0.043198},{"month":11,"riseRate":0.777778,"avgChangeRate":0.135367},{"month":12,"riseRate":0.555556,"avgChangeRate":0.004939}],"exchange":"NASDAQ","name":"ZYMEWORKS INC (US)","nameEN":"ZYMEWORKS INC (US)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ZYMEWORKS INC (US),ZYME,ZYMEWORKS INC (US)股票,ZYMEWORKS INC (US)股票老虎,ZYMEWORKS INC (US)股票老虎国际,ZYMEWORKS INC (US)行情,ZYMEWORKS INC (US)股票行情,ZYMEWORKS INC (US)股价,ZYMEWORKS INC (US)股市,ZYMEWORKS INC (US)股票价格,ZYMEWORKS INC (US)股票交易,ZYMEWORKS INC (US)股票购买,ZYMEWORKS INC (US)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYMEWORKS INC (US)(ZYME),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ZYMEWORKS INC (US)(ZYME) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}